Paper41363010
Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension.
Rossignol P and 10 others. Hypertension, 2026. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension. Papers, record 41363010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41363010
- Disease
- hypertensive disorder417 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Randomized Controlled Trial, Clinical Trial, Phase III, Multicenter Study
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypertension | Major topic |
| Renal Insufficiency, Chronic | Major topic |
| Blood Pressure | Major topic |
| Antihypertensive Agents | Major topic |
| Sulfonamides | Major topic |
| Humans | |
| Male | |
| Female | |
| Middle Aged | |
| Double-Blind Method | |
| Aged | |
| Treatment Outcome | |
| Single-Blind Method | |
| Dose-Response Relationship, Drug | |
| Drug Resistance | |
| Pyrimidines |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03541174 | A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety | Derived from the trial | Yes |
Source ClinicalTrials.gov
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21079049 | Predictive role of the nighttime blood pressure. | Hypertension | 2011 | https://conductscience.org/library/papers/21079049 | PubMed |
| 2 | 22670597 | Endothelin-1 and the kidney--beyond BP. | Br J Pharmacol | 2012 | https://conductscience.org/library/papers/22670597 | PubMed |
| 3 | 37495682 | GFR slope as a surrogate marker for future kidney failure. | Nat Rev Nephrol | 2023 | https://conductscience.org/library/papers/37495682 | PubMed |
| 4 | 36350038 | Endothelin receptor antagonists in kidney protection for diabetic kidney disease and beyond? | Nephrology (Carlton) | 2023 | https://conductscience.org/library/papers/36350038 | PubMed |
| 5 | 24952653 | Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality. | J Am Soc Hypertens | 2014 | https://conductscience.org/library/papers/24952653 | PubMed |
| 6 | 31473020 | Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency. | Am J Kidney Dis | 2020 | https://conductscience.org/library/papers/31473020 | PubMed |
| 7 | 30341579 | Prognostic value of estimated plasma volume in acute heart failure in three cohort studies. | Clin Res Cardiol | 2019 | https://conductscience.org/library/papers/30341579 | PubMed |
| 8 | 32897570 | Effects of the Dual Endothelin Receptor Antagonist Aprocitentan on Body Weight and Fluid Homeostasis in Healthy Subjects on a High Sodium Diet. | Clin Pharmacol Ther | 2021 | https://conductscience.org/library/papers/32897570 | PubMed |
| 9 | 33765691 | Endothelin receptor antagonists for pulmonary arterial hypertension. | Cochrane Database Syst Rev | 2021 | https://conductscience.org/library/papers/33765691 | PubMed |
| 10 | 12671332 | The African American Study of Kidney Disease and Hypertension (AASK) trial: what more have we learned? | J Clin Hypertens (Greenwich) | 2003 | https://conductscience.org/library/papers/12671332 | PubMed |
| 11 | 23489784 | Brain natriuretic peptide and copeptin levels are associated with cardiovascular disease in patients with chronic kidney disease. | Chin Med J (Engl) | 2013 | https://conductscience.org/library/papers/23489784 | PubMed |
| 12 | 22032706 | Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy. | J Am Coll Cardiol | 2011 | https://conductscience.org/library/papers/22032706 | PubMed |
| 13 | 35772861 | Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure. | JACC Heart Fail | 2022 | https://conductscience.org/library/papers/35772861 | PubMed |
| 14 | 37053276 | Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease. | Circ Res | 2023 | https://conductscience.org/library/papers/37053276 | PubMed |
| 15 | 35686330 | Identifying and treating resistant hypertension in PRECISION: A randomized long-term clinical trial with aprocitentan. | J Clin Hypertens (Greenwich) | 2022 | https://conductscience.org/library/papers/35686330 | PubMed |
| 16 | 39656458 | Chlorthalidone vs Hydrochlorothiazide and Kidney Outcomes in Patients With Hypertension: A Secondary Analysis of a Randomized Clinical Trial. | JAMA Netw Open | 2024 | https://conductscience.org/library/papers/39656458 | PubMed |
| 17 | 33912747 | N-Terminal Pro-B-Type Natriuretic Peptide and Incident CKD. | Kidney Int Rep | 2021 | https://conductscience.org/library/papers/33912747 | PubMed |
| 18 | 39643698 | Endothelin receptor antagonists in chronic kidney disease. | Nat Rev Nephrol | 2025 | https://conductscience.org/library/papers/39643698 | PubMed |
| 19 | 33409701 | Estimated plasma volume status in heart failure: clinical implications and future directions. | Clin Res Cardiol | 2021 | https://conductscience.org/library/papers/33409701 | PubMed |
| 20 | 40811497 | 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | Circulation | 2025 | https://conductscience.org/library/papers/40811497 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42959198 | Endothelin antagonism: a new era for resistant hypertension. | Clin Kidney J | 2026 | https://conductscience.org/library/papers/42959198 | PubMed |
| 42707992 | Endothelin receptor antagonism for resistant hypertension in chronic kidney disease: where does aprocitentan fit? | Clin Kidney J | 2026 | https://conductscience.org/library/papers/42707992 | PubMed |
| 42644854 | Endothelin Receptor Antagonists in Resistant Hypertension and Proteinuric Kidney Disease: Receptor Strategy and Volume Management. | J Clin Hypertens (Greenwich) | 2026 | https://conductscience.org/library/papers/42644854 | PubMed |
| 42230805 | Aprocitentan in resistant hypertension with chronic kidney disease: balancing albuminuria reduction against early volume risk. | J Hum Hypertens | 2026 | https://conductscience.org/library/papers/42230805 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 |
Source NCBI Gene
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| APROCITENTAN | CHEMBL2165326 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL2165326 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41363010
GET https://conductscience.org/api/papers/v1/41363010/references?page=2